Business
Award Winning Cancer Researcher, Dr. Bruce R. Zetter, Joins MetaStat, Inc. Scientific and Clinical Advisory Board
Award Winning Cancer Researcher, Dr. Bruce R. Zetter, Joins MetaStat, Inc. Scientific and Clinical Advisory Board.
About this update from Metastat Inc
[{"type":"text","content":"\nAward Winning Cancer Researcher, Dr. Bruce R. Zetter, Joins MetaStat, Inc. Scientific and Clinical Advisory Board\n\nAward Winning Cancer Researcher, Dr. Bruce R. Zetter, Joins MetaStat, Inc. Scientific and Clinical Advisory Board\n\n BOSTON, MA--(Marketwired - September 10, 2015) - MetaStat, Inc. (OTCQB: MTST), a molecular diagnostics company focused on developing and commercializing tissue-based diagnostic tests for prediction of cancer metastasis, announced today Bruce R. Zetter, PhD has joined the company's Scientific and Clinical Advisory Board. Dr. Zetter is the Charles Nowiszewski Professor in the Departments of Cell Biology and Surgery at Harvard Medical School. He is an internationally recognized leader in cancer research, tumor progression, cancer diagnosis, cancer metastasis, and tumor angiogenesis. \"We are truly thrilled to have Bruce join our team of advisors,\" said Douglas A. Hamilton, President and Chief Executive Officer of MetaStat. \"Through his groundbreaking research, Dr. Zetter's contribution to the fight against cancer is truly profound and the experience he brings to MetaStat is invaluable as we intend to expand the breadth and depth of our core diagnostic platform and future product offerings.\"Dr. Zetter conducts research at Children's Hospital, Boston where he has served as Vice President of Research and Chief Scientific Officer and is on the faculty of Harvard Medical School since 1978. At Children's Hospital, Dr. Zetter and Dr. Judah Folkman demonstrated that endothelial cells in large blood vessels are distinct from those in capillaries, a cornerstone observation in the field of angiogenesis. Dr. Zetter went on to discover the worlds' first angiogenesis inhibitor, interferon-alpha. Dr. Zetter has won numerous national and international awards for his work in the field of cancer research, including a Faculty Research Award from the American Cancer Society, a Creativity Award from the Prostate Cancer Foundation and two MERIT awards from the US National Cancer Institute. He has published more than 150 research papers and has served on the editorial boards of 11 peer-reviewed journals. He has also received three teaching awards from the students at Harvard Medical School for excellence as a teacher and as a course director. A frequent lecturer, Dr. Zetter has given over 300 lectures to universities, ...